Label-Free Electrochemical Biosensors for Triple-Negative Breast Cancer Biomarkers: Emerging Recognition Strategies, Nanomaterials, and Clinical Translation
Triple-negative breast cancer (TNBC) is when the patient does not have the three most targeted molecules (estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 or HER2) and the patient resorts to chemotherapy (cytotoxic), and poor prognosis due to the fact that the three most targeted m...